Human Papillomavirus (HPV) Vaccines

Human Papillomavirus (HPV) Vaccines Submit Abstract Register Now

Genital human papillomavirus (HPV) is the most common sexually transmitted virus in the U.S. Vaccine Can is given starting at 9 years of age. HPV is also associated with several less common types of cancer in both men and women. It can also cause genital warts and warts in the upper respiratory tract. More than 50% of sexually active men and women are infected with HPV at some time in their lives.

  • Indication and Usage – Dosage and Administration
  • Dosage Forms, Strengths and Contraindications
  • Adverse Reactions and Drug Interactions
  • HPV Vaccination
  • Contraindications and precautions

Related Conference of Human Papillomavirus (HPV) Vaccines

March 24-25, 2026

9th International Conference on Vaccines, Immunology and Clinical Trials

Paris, France
April 23-24, 2026

9th International Conference on Vaccines and Immunology

Paris, France
June 25-26, 2026

3rd Global Summit on Vaccines & Emerging Diseases

London, UK
August 27-28, 2026

7th International conference on Vaccines, Vaccination and Immunization

Paris, France
September 07-08, 2026

38th Annual Congress on Vaccine and Clinical Trials

London, UK
September 21-22, 2026

44th Euro Global Summit and Expo on Vaccines & Vaccination

Barcelona, Spain
November 16-17, 2026

7th International Conference on Vaccine Research

Tokyo, Japan

Human Papillomavirus (HPV) Vaccines Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in